Fairvalue-Calculator Fairvalue-Calculator
EN DE

Banka BioLoo Limited (BANKA) Fair Value & Analysis

Industrials · IN · Market cap ₹1.0B

Price₹90.09
Fair Value₹10.96
Upside-87.8%
Quality91/100
Evidence: Medium Range ₹5.85 – ₹13.77

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Banka BioLoo Limited (BANKA) currently trades at ₹90.09, while our model-based Fair Value estimate is ₹10.96 — implying the stock looks roughly 87.8% overvalued today. We read business quality at 91/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Banka BioLoo Limited engages in the sanitation, fecal sludge, sewage, and wastewater treatment businesses in India. It is involved in the operation, setting up, and maintenance of fecal sludge, waste water, and effluent treatment plants. The company also offers BioToilet, BioDigester, and FootLoo; packaged sewage treatment plant; and sewage treatment plant, as well as operations and management services. In addition, it is involved in manufacturing, supplying, and installation of bio toilets for Indian railways. The company provides its solutions for retail, residential, and commercial sectors. The company was incorporated in 2012 and is based in Hyderabad, India.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Banka BioLoo Limited (BANKA) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹10.96 versus a price of ₹90.09 — about −88% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BANKA?
Our 21-model fair value for Banka BioLoo Limited is ₹10.96 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹90.09.
What is the quality score of BANKA?
Banka BioLoo Limited has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.